Browse

Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis

Cited 13 time in Web of Science Cited 17 time in Scopus
Authors
Choi, Sung-E; Kang, Yup; Jang, Hyun-Ju; Shin, Ha-Chul; Kim, Hyo-Eun; Kim, Hyo-Soo; Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan-Woo
Issue Date
2007-05-08
Publisher
Karger
Citation
J Vasc Res. 2007;44(5):365-74. Epub 2007 May 4.
Keywords
Adenoviridae/geneticsAnthracenes/pharmacologyApoptosis/*drug effectsCaspase 3/metabolismCell Cycle/drug effectsCells, Cultured/cytology/drug effectsCytosol/chemistryEndothelial Cells/cytology/*drug effectsEndothelium, Vascular/*cytologyEnzyme Activation/drug effectsFumonisins/pharmacologyGenetic Vectors/pharmacologyGlycogen Synthase Kinase 3/antagonists & inhibitors/genetics/*physiologyHumansImidazoles/pharmacologyIndoles/pharmacologyLithium Chloride/pharmacologyMaleimides/pharmacologyMitochondria/chemistryPalmitates/*pharmacologyPhosphorylationPhosphoserine/metabolismPoly(ADP-ribose) Polymerases/metabolismProtein Processing, Post-Translational/drug effectsPyridines/pharmacologyThiadiazoles/pharmacologyTransduction, GeneticUmbilical Veins
Abstract
BACKGROUND/AIMS: The death of endothelial cells may play a critical role in the development of various vascular diseases, including atherosclerosis. While free fatty acids (FFAs) may stimulate endothelial apoptosis, the molecular and cellular mechanisms of this effect have not been studied intensively. To elucidate the mechanisms involved in FFA-induced endothelial cell apoptosis, we investigated the effect of different pharmacological inhibitors on palmitate-induced apoptosis in human umbilical vein endothelial cells (HUVECs). Interestingly, lithium, a glycogen synthase kinase-3 (GSK-3) inhibitor, showed a strong protective effect. METHODS AND RESULTS: To examine the involvement of GSK-3beta in palmitate-induced HUVEC apoptosis, its dephosphorylation at Ser9 and enzymatic activation in response to palmitate treatment were monitored by immunoblotting and in vitro kinase assays, respectively. GSK-3beta was dephosphorylated and its enzymatic activity increased in palmitate-treated HUVECs. In addition, pretreatment with other GSK-3beta inhibitors, e.g. SB216763 or TDZD-8, as well as adenoviral transduction with a catalytically inactive GSK-3beta had significant protective effects against palmitate-induced HUVEC apoptosis. CONCLUSION: These results demonstrate that the GSK-3beta signalling pathway is involved in palmitate-induced HUVEC apoptosis.
ISSN
1423-0135 (Electronic)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17483602

https://hdl.handle.net/10371/29253
DOI
https://doi.org/10.1159/000102321
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse